GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients

Copyright © 2010 Elsevier Inc. All rights reserved.

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 138(2011), 1 vom: 07. Jan., Seite 117-26
Auteur principal: Hjorth, Maria (Auteur)
Autres auteurs: Axelsson, Stina, Rydén, Anna, Faresjö, Maria, Ludvigsson, Johnny, Casas, Rosaura
Format: Article en ligne
Langue:English
Publié: 2011
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Alum Compounds Autoantibodies FOXP3 protein, human Forkhead Transcription Factors IL2RA protein, human Interleukin-2 Receptor alpha Subunit Interleukins plus... Transforming Growth Factor beta Tumor Necrosis Factor-alpha aluminum sulfate 34S289N54E Interferon-gamma 82115-62-6 Glutamate Decarboxylase EC 4.1.1.15 glutamate decarboxylase 2